Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E45 emollient therapy versus usual emollient regimen for mild to moderate atopic eczema
2006-000877-30Phase 4Completed
- Sponsor
- Reckitt
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lauromacrogols + urea and E45 complete emollient therapy in atopic dermatitis (AD) (2 arms), sponsored by Reckitt. Primary endpoints: Primary efficacy endpoints, Quality of life and 2 more. Started Apr 2006; status: completed.
02
Drugs
lauromacrogols + ureaE45 complete emollient therapy
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-000877-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000877-30.